These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7352591)

  • 1. Patients at risk of developing severe side effects from depot fluphenazine treatment.
    Blum A
    Am J Psychiatry; 1980 Feb; 137(2):254-5. PubMed ID: 7352591
    [No Abstract]   [Full Text] [Related]  

  • 2. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fluspirilen and fluphenazine in schizophrenic patients. Comparative study].
    Magnus RV
    MMW Munch Med Wochenschr; 1980 Dec; 122(49):1758-60. PubMed ID: 6779147
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostic significance of selected side effects occurring in the course of prolonged-action fluphenazine treatment].
    Koślacz A; Popkowska N; Kulesza E; Lysikowska-Prokop L; Marmurowska-Michalowska H; Perzyński J
    Psychiatr Pol; 1977; 11(2):159-64. PubMed ID: 887674
    [No Abstract]   [Full Text] [Related]  

  • 5. Delayed severe extrapyramidal disturbance following frequent depot phenothiazine administration.
    Warner AM; Wyman SM
    Am J Psychiatry; 1975 Jul; 132(7):743-5. PubMed ID: 1137022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G; Annable L; Ross-Chouinard A
    Am J Psychiatry; 1982 Mar; 139(3):312-8. PubMed ID: 6120655
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate.
    Kane J; Quitkin F; Rifkin A; Klein DF
    Am J Psychiatry; 1978 Dec; 135(12):1539-42. PubMed ID: 717574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effects of depot fluphenazines.
    Ayd FJ
    Adv Biochem Psychopharmacol; 1974; 9(0):301-9. PubMed ID: 4599435
    [No Abstract]   [Full Text] [Related]  

  • 9. Iatrogenic morbidity in patients taking depot fluphenazine.
    Jose C; Mallya A; Mehta D; Evenson R; Holland R
    Am J Psychiatry; 1979 Jul; 136(7):976-7. PubMed ID: 453363
    [No Abstract]   [Full Text] [Related]  

  • 10. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapyramidal symptoms in the course of fluphenazine treatment.
    Bastecký J; Vinar O; Taussigová D
    Act Nerv Super (Praha); 1972; 14(2):97-9. PubMed ID: 5040184
    [No Abstract]   [Full Text] [Related]  

  • 12. The depot fluphenazines: a reappraisal after 10 years' clinical experience.
    Ayd FJ
    Am J Psychiatry; 1975 May; 132(5):491-500. PubMed ID: 1091162
    [No Abstract]   [Full Text] [Related]  

  • 13. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
    Knights A; Okasha MS; Salih MA; Hirsch SR
    Br J Psychiatry; 1979 Dec; 135():515-23. PubMed ID: 394794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy with injectable fluphenazines.
    Ayd FJ
    Curr Psychiatr Ther; 1976; 16():177-89. PubMed ID: 991628
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of fluphenazine enanthate in psychotic patients.
    Routsonis KG; Photiadis H
    Curr Ther Res Clin Exp; 1973 Mar; 15(3):92-6. PubMed ID: 4196232
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate.
    Gelenberg AJ; Doller JC; Schooler NR; Mieske M; Severe J; Mandel MR
    Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia.
    Carney MW; Sheffield BF
    Br J Psychiatry; 1976 Nov; 129():476-81. PubMed ID: 990663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrapyramidal reaction to fluphenazine potentiated by thyrotoxicosis.
    Witschy JK; Redmond FC
    Am J Psychiatry; 1981 Feb; 138(2):246-7. PubMed ID: 7457650
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical observations of treatment with Lyorodin-depot (Jenapharm)].
    Pirozynski T; Chiriţă V; Cosmovici N; Offenberg C; Chiriac ME; Marinescu V; Cojocaru M; Berlescu M; Mungiu A
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):501-9. PubMed ID: 2700035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings].
    Rifkin A; Quitkin F; Kane J; Klein DF
    Psychopharmacol Bull; 1977 Apr; 13(2):49-50. PubMed ID: 323910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.